PPARγ Attenuates Interleukin-1β-Induced Cell Apoptosis by Inhibiting NOX2/ROS/p38MAPK Activation in Osteoarthritis...

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Osteoarthritis (OA) chondrocytes exhibit increased inflammatory mediator expression upon stimulation by extracellular cytokines.
• Reactive oxygen species (ROS) play a crucial role in cytokine-induced inflammation within OA chondrocytes.
• Peroxisome proliferator-activated receptor gamma (PPARγ) is known to possess anti-inflammatory properties.

Purpose of the Study:

• To investigate the role of PPARγ in interleukin-1 beta (IL-1β)-induced cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) expression.
• To elucidate the involvement of ROS generation in the IL-1β signaling pathway leading to inflammation in OA chondrocytes.
• To determine the mechanism by which PPARγ modulates IL-1β-induced inflammatory responses.

Main Methods:

• Quantification of ROS generation and chondrocyte apoptosis using flow cytometry.
• Biochemical assays to measure NADPH oxidase (NOX), caspase-3, and caspase-9 levels.
• Pharmacological inhibition and western blotting to assess the roles of NOX2, mitogen-activated protein kinases (MAPKs), and PPARγ activation.

Main Results:

• IL-1β-induced COX-2 and PGE2 expression is mediated by NOX2 activation and subsequent ROS production.
• ROS generation activates p38MAPK, leading to its nuclear translocation.
• PPARγ activation, along with ROS scavengers and NOX2/MAPK inhibitors, attenuated IL-1β-induced inflammatory mediator expression.

Conclusions:

• In OA chondrocytes, IL-1β induces COX-2 and PGE2 expression through NOX2 activation, ROS production, and MAPK signaling.
• PPARγ activation demonstrates a protective effect against the inflammatory pathogenesis of OA.
• Targeting the NOX2-ROS-MAPK pathway and activating PPARγ represent potential therapeutic strategies for OA.